Next Article in Journal
Synthesis, Singlet Oxygen Photogeneration and DNA Photocleavage of Porphyrins with Nitrogen Heterocycle Tails
Next Article in Special Issue
Gombapyrones E and F, New α-Pyrone Polyenes Produced by Streptomyces sp. KMC-002
Previous Article in Journal
Thiophene Derivatives with Antileishmanial Activity Isolated from Aerial Parts of Porophyllum ruderale (Jacq.) Cass.
Previous Article in Special Issue
Assessment of the In Vivo Genotoxicity of New Lead Compounds to Treat Sickle Cell Disease
Molecules 2011, 16(5), 3479-3487; doi:10.3390/molecules16053479
Article

Study of the Biological Activity of Novel Synthetic Compounds with Antiviral Properties against Human Rhinoviruses

* ,  and
Received: 9 February 2011 / Revised: 6 April 2011 / Accepted: 20 April 2011 / Published: 26 April 2011
(This article belongs to the collection Bioactive Compounds)
Download PDF [246 KB, 18 June 2014; original version 18 June 2014]

Abstract

Picornaviridae represent a very large family of small RNA viruses, some of which are the cause of important human and animal diseases. Since no specific therapy against any of these viruses currently exists, palliative symptomatic treatments are employed. The early steps of the picornavirus replicative cycle seem to be privileged targets for some antiviral compounds like disoxaril and pirodavir. Pirodavir’s main weakness is its cytotoxicity on cell cultures at relatively low doses. In this work some original synthetic compounds were tested, in order to find less toxic compounds with an improved protection index (PI) on infected cells. Using an amino group to substitute the oxygen atom in the central chain, such as that in the control molecule pirodavir, resulted in decreased activity against Rhinoviruses and Polioviruses. The presence of an -ethoxy-propoxy- group in the central chain (as in compound I-6602) resulted in decreased cell toxicity and in improved anti-Rhinovirus activity. This compound actually showed a PI >700 on HRV14, while pirodavir had a PI of 250. These results demonstrate that modification of pirodavir’s central hydrocarbon chain can lead to the production of novel derivatives with low cytotoxicity and improved PI against some strains of Rhinoviruses.
Keywords: antivirals; rhinoviruses; pirodavir antivirals; rhinoviruses; pirodavir
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote
MDPI and ACS Style

Laconi, S.; Madeddu, M.A.; Pompei, R. Study of the Biological Activity of Novel Synthetic Compounds with Antiviral Properties against Human Rhinoviruses. Molecules 2011, 16, 3479-3487.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here

Comments

Cited By

[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert